Guggenheim Capital LLC Insulet Corp Transaction History
Guggenheim Capital LLC
- $14 Billion
- Q3 2024
A detailed history of Guggenheim Capital LLC transactions in Insulet Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 17,800 shares of PODD stock, worth $4.96 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,800
Previous 10,158
75.23%
Holding current value
$4.96 Million
Previous $2.05 Million
102.15%
% of portfolio
0.03%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding PODD
# of Institutions
713Shares Held
62.9MCall Options Held
640KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.36 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.17 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.69 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$813 Million0.03% of portfolio
-
Baillie Gifford & CO2.36MShares$657 Million0.49% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $19.4B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...